New Chinese Weight-Loss Injection Ribupatide Shows Over 17% Weight Loss In 48 Weeks: Could It Rival Mounjaro?

New Chinese Weight-Loss Injection Ribupatide Shows Over 17% Weight Loss In 48 Weeks: Could It Rival Mounjaro?

Credit: AI-generated image

Text

Updated Nov 16, 2026 | 07:43 AM IST

SummaryRibupatide, an experimental weight loss injection being developed in China, showed promise in recent clinical trial by delivering at least 17.7% weight loss in 48 weeks.

End of Article